Union européenne - français - EMA (European Medicines Agency)

kyowa kirin holdings b.v. - burosumab - hypophosphatemia, familial; hypophosphatemic rickets, x-linked dominant; osteomalacia - médicaments pour le traitement des maladies osseuses - crysvita is indicated for the treatment of x-linked hypophosphataemia, in children and adolescents aged 1 to 17 years with radiographic evidence of bone disease, and in adults. crysvita is indicated for the treatment of fgf23-related hypophosphataemia in tumour-induced osteomalacia associated with phosphaturic mesenchymal tumours that cannot be curatively resected or localised in children and adolescents aged 1 to 17 years and in adults.

Canada - français - Health Canada

kyowa kirin, inc. - burosumab - solution - 10mg - burosumab 10mg - electrolytic, caloric and water balance agents, miscellanous

Canada - français - Health Canada

kyowa kirin, inc. - burosumab - solution - 20mg - burosumab 20mg - electrolytic, caloric and water balance agents, miscellanous

Canada - français - Health Canada

kyowa kirin, inc. - burosumab - solution - 30mg - burosumab 30mg - electrolytic, caloric and water balance agents, miscellanous

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

kyowa kirin sàrl - burosumabum - solution injectable - burosumabum 10 mg, histidinum, sorbitolum, polysorbatum 80, methioninum, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - x-chromosomaler hypophosphatämie (xlh) bei erwachsenen, jugendlichen und kindern ab 1 jahr - biotechnologika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

kyowa kirin sàrl - burosumabum - solution injectable - burosumabum 20 mg, histidinum, sorbitolum, polysorbatum 80, methioninum, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - x-chromosomaler hypophosphatämie (xlh) bei erwachsenen, jugendlichen und kindern ab 1 jahr - biotechnologika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

kyowa kirin sàrl - burosumabum - solution injectable - burosumabum 30 mg, histidinum, sorbitolum, polysorbatum 80, methioninum, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - x-chromosomaler hypophosphatämie (xlh) bei erwachsenen, jugendlichen und kindern ab 1 jahr - biotechnologika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

shi homöopathie ag - barosma - lm/q1, d; tm, t; tm, d; k30, d - homöopathisch

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

boiron sa - barosma - tm, d; tm, d - homöopathisch

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

boiron sa - barosma - k30, d; lm/q1, d - homöopathisch